Ernexa Therapeutics Inc. Warrants (ERNAW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.9x

Market Cap

$328259.25

MomentumView details →

1D Return

−8.13%

YTD Return

—

RSI (14)

45.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.9x

Market Cap

$328259.25

RSI (14)

45.2

MomentumView details →

1D Return

−8.13%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−166.02%

ROA (TTM)

−108.01%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−$3.84

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

2.89x

Quick Ratio

2.89x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−11.39M

Op. CF (TTM)

−7.22M

Next earningsNov 11, 2026 →

Latest newsMore news →

Ernexa Therapeutics appointed David Polinsky, a veteran biotech executive, to its board of directors as the company approaches the clinical stage.25d ago

Ernexa Therapeutics receives independent validation of its drug ERNA-101 in ovarian cancer models, showing complete tumor clearance and durable survival, ahead of planned clinical entry.51d ago

Similar companies

Starry Sea Acquisition Corp RightsSSEAR GCM Grosvenor Inc.GCMGW AlphaTON Capital Corp.ATON StoneBridge Acquisition II Corporation RightsAPACR VisionWave Holdings, Inc. WarrantVWAVW Calisa Acquisition Corp RightALISR Find similar companies →

Latest newsMore news →

Ernexa Therapeutics appointed David Polinsky, a veteran biotech executive, to its board of directors as the company approaches the clinical stage.25d ago Ernexa Therapeutics receives independent validation of its drug ERNA-101 in ovarian cancer models, showing complete tumor clearance and durable survival, ahead of planned clinical entry.51d ago